Biosynex Stock OTC Markets

BSYXF

FR0011005933

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Sep. 04	Biosynex: creditors to vote on financial safeguard plan
Aug. 06	Biosynex hit by cyberattack, operational activity remains intact

News in other languages : Biosynex

Sep. 04	Biosynex : vote des créanciers sur le plan de sauvegarde financière
Sep. 04	BIOSYNEX SA: Notification des créanciers de Biosynex réunis en classes de parties affectées pour voter sur le projet de plan de sauvegarde - Principaux termes du projet de plan de sauvegarde
Sep. 01	Biosynex : Thierry Paper quitte ses fonctions avec effet immédiat
Sep. 01	BIOSYNEX SA: Départ de Monsieur Thierry Paper
Aug. 07	Bourse : Eutelsat souffre, la tech américaine s'offre un baroud d'honneur nocturne

More news

Managers and Directors : Biosynex

Manager	Title	Age	Since
Larry Abensur CEO	Chief Executive Officer	71	2015-06-23
Thierry Paper CTO	Chief Tech/Sci/R&D Officer	63	2014-12-31
Oren Bitton PRN	Corporate Officer/Principal	-	-

Director	Title	Age	Since
Thierry Paper BRD	Director/Board Member	63	2015-06-23
Thomas Lamy BRD	Director/Board Member	-	2015-06-23
Larry Abensur CHM	Chairman	71	2015-06-23

More insiders

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOSYNEX	-.--%	-.--%	-	-	19.3M
GUARDANT HEALTH, INC.	-1.04%	-2.50%	+186.69%	+384.25%	21.13B
BIOMÉRIEUX	-1.68%	-5.19%	-38.84%	-22.11%	9.62B
10X GENOMICS, INC.	+3.33%	+9.48%	+442.64%	+38.20%	8.94B
CARIS LIFE SCIENCES, INC.	+1.25%	-2.91%	-28.54%	-	6.88B
LANTHEUS HOLDINGS, INC.	-0.14%	-0.71%	+89.37%	+56.40%	6.54B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	0.00%	-6.45%	-29.52%	-23.10%	5.64B
DIASORIN S.P.A.	-0.27%	-2.60%	-7.25%	-19.83%	4.22B
ANDON HEALTH CO., LTD.	-1.59%	-9.17%	+56.51%	+67.85%	3.84B
AUTOBIO DIAGNOSTICS CO., LTD.	-3.08%	-5.58%	-24.29%	-32.36%	2.65B
Average	-0.32%	-2.87%	+71.86%	+56.16%	7.72B
Weighted average by Cap.	-0.23%	-2.02%	+113.33%	+137.07%

See all sector performances

Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.

Employees

397

Sector

Medical Equipment, Supplies & Distribution

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	16.63M 19.3M 15.74M 14.27M 26.77M 1.84B 26.9M 187M 71.9M 938M 72.47M 70.88M 2.96B	P/E 2024	-0.43x	P/E 2025	-0.19x
Enterprise Value	69.82M 81.03M 66.11M 59.92M 112M 7.74B 113M 785M 302M 3.94B 304M 298M 12.44B	EV / Sales 2024	0.71x	EV / Sales 2025	0.68x
Free-Float	40.35%	Yield 2024 *	-	Yield 2025	-

Sep. 04	Biosynex: creditors to vote on financial safeguard plan
Aug. 06	Biosynex hit by cyberattack, operational activity remains intact
Jun. 11	Triple update for Biosynex
Jun. 10	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
May. 25	Paris climbs on hopes of Middle East de-escalation
May. 25	Biosynex announces the divestment of its molecular biology business
May. 24	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
May. 07	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
May. 06	Biosynex SA Auditor Raises 'Going Concern' Doubt	CI
Apr. 21	Thales, Vivendi, Mercialys, GTT... stocks to watch today in Paris
Apr. 21	Biosynex postpones publication of annual accounts
Mar. 24	Abivax, Ekinops, Sanofi... stocks to watch today in Paris
Mar. 24	Observation period extended for Biosynex

24-10-23	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY	EQ
23-04-27	Biosynex Completes Acquisition of Chembio Diagnostics, Inc.	AQ
23-04-13	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
23-03-15	Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.	AQ
23-01-31	Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement	AQ

	2024	2025
Net sales	101M 117M 95.79M 86.83M 163M 11.22B 164M 1.14B 437M 5.71B 441M 431M 18.03B	95.19M 110M 90.14M 81.7M 153M 10.56B 154M 1.07B 412M 5.37B 415M 406M 16.97B
Net income	-43.33M -50.29M -41.03M -37.19M -69.77M -4.8B -70.12M -487M -187M -2.44B -189M -185M -7.72B	-58.22M -67.58M -55.13M -49.97M -93.75M -6.46B -94.22M -655M -252M -3.28B -254M -248M -10.38B
Net Debt	52.94M 61.44M 50.12M 45.43M 85.23M 5.87B 85.66M 595M 229M 2.99B 231M 226M 9.44B	53.19M 61.73M 50.36M 45.65M 85.64M 5.9B 86.08M 598M 230M 3B 232M 227M 9.48B

Biosynex Stock OTC Markets

Stocks

BSYXF

FR0011005933

Medical Equipment, Supplies & Distribution

Valuation : Biosynex

Latest news : Biosynex

Press Releases : Biosynex

News in other languages : Biosynex

Managers and Directors : Biosynex

Diagnostic & Testing Substances

Financials

Company Profile